The Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose We investigated 18F-fluorodeoxyglucose positron emission tomography (PET)-derived parameters as prognostic indices for disease progression and survival in locally advanced nasopharyngeal carcinoma (NPC) and the effect of high-dose radiotherapy for a subpopulation with PET-based poor prognoses. Materials and Methods Ninety-seven stage III and Iva-b NPC patients who underwent definitive treatment and PET were reviewed. For each primary, nodal, and whole tumor, maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis (TLG) were evaluated. Results Based on the C-index (0.666) and incremental area under the curve (0.669), the whole tumor TLG was the most useful predictor for progression-free survival (PFS); the whole tumor TLG cut-off value showing the best predictive performance was 322.7. In multivariate analysis, whole tumor TLG was a significant prognostic factor for PFS (hazard ratio [HR], 0.3; 95% confidence interval [CI], 0.14 to 0.65; p=0.002) and OS (HR, 0.29; 95% CI, 0.11 to 0.79; p=0.02). Patients with low whole tumor TLG showed the higher 5-year PFS in the subgroup for only patients receiving intensity modulated radiotherapy (77.4% vs. 53.0%, p=0.01). In the subgroup of patients with high whole tumor TLG, patients receiving an EQD2 ! 70 Gy showed significantly greater complete remission rates (71.4% vs. 33.3%, p=0.03) and higher 5-year OS (74.7% vs. 19.6%, p=0.02). Conclusion Our findings demonstrated that whole tumor TLG could be an independent prognostic factor and high-dose radiotherapy could improve outcomes for NPC showing high whole tumor TLG.
Abstract
Purpose We investigated 18F-fluorodeoxyglucose positron emission tomography (PET)-derived parameters as prognostic indices for disease progression and survival in locally advanced nasopharyngeal carcinoma (NPC) and the effect of high-dose radiotherapy for a subpopulation with PET-based poor prognoses. Materials and Methods Ninety-seven stage III and Iva-b NPC patients who underwent definitive treatment and PET were reviewed. For each primary, nodal, and whole tumor, maximum standardized uptake value, metabolic tumor volume, and total lesion glycolysis (TLG) were evaluated. Results Based on the C-index (0.666) and incremental area under the curve (0.669), the whole tumor TLG was the most useful predictor for progression-free survival (PFS); the whole tumor TLG cut-off value showing the best predictive performance was 322.7. In multivariate analysis, whole tumor TLG was a significant prognostic factor for PFS (hazard ratio [HR], 0.3; 95% confidence interval [CI], 0.14 to 0.65; p=0.002) and OS (HR, 0.29; 95% CI, 0.11 to 0.79; p=0.02). Patients with low whole tumor TLG showed the higher 5-year PFS in the subgroup for only patients receiving intensity modulated radiotherapy (77.4% vs. 53.0%, p=0.01). In the subgroup of patients with high whole tumor TLG, patients receiving an EQD2 ! 70 Gy showed significantly greater complete remission rates (71.4% vs. 33.3%, p=0.03) and higher 5-year OS (74.7% vs. 19.6%, p=0.02). Conclusion Our findings demonstrated that whole tumor TLG could be an independent prognostic factor and high-dose radiotherapy could improve outcomes for NPC showing high whole tumor TLG.
참고문헌 (25)
- Yi JL, "Nasopharyngeal carcinoma treated by radical radiotherapy alone : Ten-year experience of a single institution", Int J Radiat Oncol Biol Phys, 65, pp.161~168 (2006)
- Baujat B, "Chemotherapy in locally advanced nasopharyngeal carcinoma : an individual patient data meta-analysis of eight randomized trials and 1753 patients", Int J Radiat Oncol Biol Phys, 64, pp.47~56 (2006)
- Ng WT, "Clinical outcomes and patterns of failure after intensitymodulated radiotherapy for nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 79, pp.420~428 (2011)
- Lin JC, "Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma : positive effect on overall and progression-free survival", J Clin Oncol, 21, pp.631~637 (2003)
- Wu F, "Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : treatment outcomes of a prospective, multicentric clinical study", Radiother Oncol, 112, pp.106~111 (2014)
- Lee N, "Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma : radiation therapy oncology group phase II trial 0225", J Clin Oncol, 27, pp.3684~3690 (2009)
- fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma : a multicenter prospective study, "J Clin Oncol", 2010, 1190~1195
- Chang JT, "Nasopharyngeal carcinoma staging by(18)F-fluorodeoxyglucose positron emission tomography", Int J Radiat Oncol Biol Phys, 62, pp.501~507 (2005)
- Liu FY, "18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma", J Nucl Med, 48, pp.1614~1619 (2007)
- Xie P, "Prognostic value of 18F-FDG PET", CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma, 2010, pp.21, 1078~1082
- Hung TM, "Pretreatment(18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma", Oral Oncol, 49, pp.169~174 (2013)
- Chang KP, "Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma", J Nucl Med, 53, pp.21~28 (2012)
- Edge SB, "AJCC cancer staging manual" (2010), Springer
- Kim JW, "IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome", Jpn J Clin Oncol, 42, pp.1152~1160 (2012)
- Yun M, "Lymph node staging of gastric cancer using 18F-FDG PET:a comparison study with CT", J Nucl Med, 46, pp.1582~1588 (2005)
- Liao S, "Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer", Eur J Nucl Med Mol Imaging, 39, pp.27~38 (2012)
- Lee JW, "Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET", CT in patients with pancreatic cancer, 2014, pp.55, 898~904
- Tripepi G, "Statistical methods for the assessment of prognostic biomarkers(Part I) : discrimination", Nephrol Dial Transplant, 25, pp.1399~1401 (2010)
- Contal C, "An application of changepoint methods in studying the effect of age on survival in breast cancer", Comput Stat Data Anal, 30, pp.253~270 (1999)
- Ryu IS, "Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET", CT in salivary gland carcinomas, 2013, pp.54, 1032~1038
- Chan WK, "Nasopharyngeal carcinoma : relationship between 18FFDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification", Nucl Med Commun, 31, pp.206~210 (2010)
- Chan SC, "Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma : predictive role for different survival endpoints and impact on prognostic stratification", Nucl Med Commun, 32, pp.989~996 (2011)
- Xiao WW, "Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy : long-term results of a phase 2 study", Cancer, 117, pp.1874~1883 (2011)
- Bakst RL, "Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma : a prospective trial", Int J Radiat Oncol Biol Phys, 80, pp.148~153 (2011)
- "NCCN clinical practice guidelines in Oncology: head and neck cancers" (2015)[URL]